Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemokines and thrombogenicity.

Michele P Lambert1, Bruce S Sachais, M Anna Kowalska

  • 1Division of Hematology, Children's Hospital of Philadelphia, 3615 Civic Center Blvd ARC Rm. 316I, Philadelphia, PA 19104, USA.

Thrombosis and Haemostasis
|May 5, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric autoimmune hemolytic anemia is associated with a high incidence of underlying immune disorders.

Blood advances·2026
Same author

Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorder.

Blood·2026
Same author

The association between immature platelet count and clinical characteristics in pediatric immune thrombocytopenia.

Research and practice in thrombosis and haemostasis·2026
Same author

Novel RHCE*cE(341A) allele.

Transfusion·2026
Same author

Enhancing Immune Thrombocytopenia Education and Support: Insights From a Learning Exchange Program.

Journal of the advanced practitioner in oncology·2026
Same author

Treatment Strategies and Outcomes in Pediatric Patients With Immune Thrombocytopenia Undergoing Surgical Procedures: A Multicenter Study.

Pediatric blood & cancer·2026
Same journal

Discontinuation of Oral Anticoagulation After Successful Catheter Ablation for Atrial Fibrillation: Meta-analysis of Randomized Clinical Trials.

Thrombosis and haemostasis·2026
Same journal

Novel/Recurrent Variants in Pakistani Glanzmann Thrombasthenia and Glanzmann-like bleeding diathesis: Insights from NGS Analysis.

Thrombosis and haemostasis·2026
Same journal

Anti-TFPI Single-Domain Antibodies: Novel Rebalancing Therapies for Hemophilia and Other Rare Bleeding Disorders.

Thrombosis and haemostasis·2026
Same journal

The Interaction of Fibrin with Endothelial Cell Receptor N-Cadherin Promotes Fibrin-Dependent Angiogenesis.

Thrombosis and haemostasis·2026
Same journal

Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study Design.

Thrombosis and haemostasis·2026
Same journal

Prasugrel vs. Ticagrelor: Can TUXEDO-2 Settle the Debate?

Thrombosis and haemostasis·2026
See all related articles

Chemokines, inflammation factors, play a key role in thrombosis and atherosclerosis. Platelet chemokines can influence thrombus formation and inflammation, requiring further study.

Area of Science:

  • Cardiovascular biology
  • Inflammation research
  • Hematology

Background:

  • Thrombosis, particularly atherosclerosis, is a significant cause of illness and death.
  • Chemokines, typically involved in inflammation, are increasingly recognized for their role in thrombogenesis.
  • Platelet-derived chemokines can modulate both thrombosis and inflammatory processes.

Purpose of the Study:

  • To review the role of chemokines in platelet activation and thrombosis.
  • To highlight the specific involvement of chemokines in atherosclerosis.
  • To synthesize current understanding of chemokine involvement in thrombogenesis.

Main Methods:

  • Review of recent studies, including murine transgenic and knockout models.
  • Analysis of scientific literature on chemokines, platelets, and thrombosis.

Related Experiment Videos

  • Focus on studies investigating chemokine-receptor interactions in thrombus formation.

    • Main Results:

    • Chemokines and their receptors are significant modulators of thrombus formation, especially in atherosclerosis.
    • Platelet chemokines have a dual role, potentially potentiating or inhibiting thrombosis and inflammation.
    • Evidence suggests a complex interplay between chemokines, platelets, and the thrombotic process.

    Conclusions:

    • Chemokines are critical players in the pathogenesis of atherosclerosis-related thrombosis.
    • Understanding chemokine function in platelet activation is crucial for therapeutic strategies.
    • Further research is needed to fully elucidate the complex interactions involved.